ACS Publications. Most Trusted. Most Cited. Most Read
HACE2-Exosome-Based Nano-Bait for Concurrent SARS-CoV-2 Trapping and Antioxidant Therapy
My Activity

Figure 1Loading Img
    Biological and Medical Applications of Materials and Interfaces

    HACE2-Exosome-Based Nano-Bait for Concurrent SARS-CoV-2 Trapping and Antioxidant Therapy
    Click to copy article linkArticle link copied!

    • Xiaoyi Ma
      Xiaoyi Ma
      Shanghai Skin Disease Hospital, The Institute for Biomedical Engineering & Nano Science, Tongji University School of Medicine, Shanghai 200092, P. R. China
      More by Xiaoyi Ma
    • Shiyu Guo
      Shiyu Guo
      Department of Pharmacology, Tongji University School of Medicine, Shanghai Tenth People’s Hospital, Shanghai 200092, P. R. China
      More by Shiyu Guo
    • Shuangrong Ruan
      Shuangrong Ruan
      Shanghai Skin Disease Hospital, The Institute for Biomedical Engineering & Nano Science, Tongji University School of Medicine, Shanghai 200092, P. R. China
    • Yao Liu
      Yao Liu
      Shanghai Skin Disease Hospital, The Institute for Biomedical Engineering & Nano Science, Tongji University School of Medicine, Shanghai 200092, P. R. China
      More by Yao Liu
    • Jie Zang
      Jie Zang
      Shanghai Skin Disease Hospital, The Institute for Biomedical Engineering & Nano Science, Tongji University School of Medicine, Shanghai 200092, P. R. China
      More by Jie Zang
    • Yushan Yang
      Yushan Yang
      Shanghai Skin Disease Hospital, The Institute for Biomedical Engineering & Nano Science, Tongji University School of Medicine, Shanghai 200092, P. R. China
      More by Yushan Yang
    • Haiqing Dong
      Haiqing Dong
      Shanghai Skin Disease Hospital, The Institute for Biomedical Engineering & Nano Science, Tongji University School of Medicine, Shanghai 200092, P. R. China
      More by Haiqing Dong
    • Yan Li
      Yan Li
      Shanghai Skin Disease Hospital, The Institute for Biomedical Engineering & Nano Science, Tongji University School of Medicine, Shanghai 200092, P. R. China
      More by Yan Li
    • Tianbin Ren*
      Tianbin Ren
      Shanghai Skin Disease Hospital, The Institute for Biomedical Engineering & Nano Science, Tongji University School of Medicine, Shanghai 200092, P. R. China
      *Email: [email protected]
      More by Tianbin Ren
    • Maomao An*
      Maomao An
      Department of Pharmacology, Tongji University School of Medicine, Shanghai Tenth People’s Hospital, Shanghai 200092, P. R. China
      *Email: [email protected]
      More by Maomao An
    • Yongyong Li*
      Yongyong Li
      Shanghai Skin Disease Hospital, The Institute for Biomedical Engineering & Nano Science, Tongji University School of Medicine, Shanghai 200092, P. R. China
      *Email: [email protected]
      More by Yongyong Li
    Other Access OptionsSupporting Information (1)

    ACS Applied Materials & Interfaces

    Cite this: ACS Appl. Mater. Interfaces 2022, 14, 4, 4882–4891
    Click to copy citationCitation copied!
    https://doi.org/10.1021/acsami.1c19541
    Published January 22, 2022
    Copyright © 2022 American Chemical Society

    Abstract

    Click to copy section linkSection link copied!
    Abstract Image

    Corona Virus Disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is seriously threatening human health. Following SARS-CoV-2 infection, immune cell infiltration creates an inflammatory and oxidative microenvironment, which can cause pneumonia, severe acute respiratory syndrome, kidney failure, and even death. Clinically, a safe and effective treatment strategy remains to be established. Herein, a nano-bait strategy for inhibition of SARS-CoV-2 infection by redirecting viral attack while simultaneously relieving inflammation is developed. Specifically, the nano-bait was based on the exosome-sheathed polydopamine (PDA@Exosome) nanoparticles, which were generated by exocytosis of the PDA nanoparticles from H293T cells. In this approach, PDA@Exosome inherits from the source cells of H293T cells a surface display of ACE2 through pre-engineered expression. The resulting PDA@Exosome can compete with ACE2-expressing epithelial cells for S protein binding, in either the pre-exposure or post-exposure route. Moreover, relying on the ability of PDA to intercept and deactivate radical species, the PDA@Exosome can significantly attenuate the level of inflammatory cytokines by mediating oxidative stress, a major cause of organ injury. Due to its high trapping, multiple antioxidant ability, and good biocompatibility, the HACE2-exosome based nano-bait is a promising robust antiviral nanotherapeutics for the ongoing COVID-19 pandemic.

    Copyright © 2022 American Chemical Society

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.

    Recommended

    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. Add or change your institution or let them know you’d like them to include access.

    Supporting Information

    Click to copy section linkSection link copied!

    The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsami.1c19541.

    • Hydrodynamic diameter of PDA@Exosome incubated in PBS with or without 10% FBS for different durations; phagocytosis of PDA by H293T cells characterized by a living cell workstation; investigation of the cellular uptake mechanism of PDA by using endocytosis inhibitors; time-dependent experiments of S protein binding to 293T cells characterized by living cell workstation; schematic illustration of the binding experiments; fluorescence images and semiquantitative analysis of cells after incubation with G5 and G6 groups; and fluorescence images of FITC-labeled S protein combined with PDA-Rho@Exosome (PDF)

    Terms & Conditions

    Electronic Supporting Information files are available without a subscription to ACS Web Editions. The American Chemical Society holds a copyright ownership interest in any copyrightable Supporting Information. Files available from the ACS website may be downloaded for personal use only. Users are not otherwise permitted to reproduce, republish, redistribute, or sell any Supporting Information from the ACS website, either in whole or in part, in either machine-readable form or any other form without permission from the American Chemical Society. For permission to reproduce, republish and redistribute this material, requesters must process their own requests via the RightsLink permission system. Information about how to use the RightsLink permission system can be found at http://pubs.acs.org/page/copyright/permissions.html.

    Cited By

    Click to copy section linkSection link copied!
    Citation Statements
    Explore this article's citation statements on scite.ai

    This article is cited by 20 publications.

    1. Bin Tu, Zhenzhen Pan, Huiyuan Wang, Jingkun Qu, Feifei Sun, Mingjie Shi, Yingyan Zhang, Han Wu, Bahtiyor Muhitdinov, Yongzhuo Huang. Heparin-Conjugated ACE2-Bearing Extracellular Vesicles As Engineered Dual-Decoy for Combating the SARS-CoV-2 Omicron Variant via Pulmonary Delivery. ACS Materials Letters 2024, 6 (4) , 1247-1255. https://doi.org/10.1021/acsmaterialslett.3c01442
    2. Lianghui Huang, Enguang Wu, Jiawei Liao, Zongyi Wei, Jin Wang, Zhenhua Chen. Research Advances of Engineered Exosomes as Drug Delivery Carrier. ACS Omega 2023, 8 (46) , 43374-43387. https://doi.org/10.1021/acsomega.3c04479
    3. Lihuan Shang, Qi Xie, Conglian Yang, Li Kong, Zhiping Zhang. Extracellular Vesicles Facilitate the Transportation of Nanoparticles within and between Cells for Enhanced Tumor Therapy. ACS Applied Materials & Interfaces 2023, 15 (36) , 42378-42394. https://doi.org/10.1021/acsami.3c10237
    4. Zhengyan Gu, Wenjun Xue, Guanchao Mao, Zhipeng Pei, Jingjing Li, Mingxue Sun, Xinkang Zhang, Shanshan Zhang, Songling Li, Jinfeng Cen, Kai Xiao, Ying Lu, Qingqiang Xu. Native and Engineered Extracellular Vesicles for the Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome. Small Science 2025, 5 (6) https://doi.org/10.1002/smsc.202400606
    5. A. P. Athira, Smrithi Sreekanth, Ananthu Chandran, Anismrita Lahon. Dual Role of Extracellular Vesicles as Orchestrators of Emerging and Reemerging Virus Infections. Cell Biochemistry and Biophysics 2025, 83 (1) , 159-175. https://doi.org/10.1007/s12013-024-01495-3
    6. Rongjie Zhang, Xin Zhang, Xuhui Zhu, Tao Li, Yansheng Li, Peng Zhang, Yuanhao Chen, Gao Li, Xiuwu Han. Nanoparticles transfected with plasmid-encoded lncRNA-OIP5-AS1 inhibit renal ischemia-reperfusion injury in mice via the miR-410-3p/Nrf2 axis. Renal Failure 2024, 46 (1) https://doi.org/10.1080/0886022X.2024.2319327
    7. Jiayuan Li, Haiqing Xiao, Chang Zhang, Gang Liu, Xuan Liu. From virus to immune system: Harnessing membrane‐derived vesicles to fight COVID‐19 by interacting with biological molecules. European Journal of Immunology 2024, 54 (9) https://doi.org/10.1002/eji.202350916
    8. Xi Lv, Ran Chen, Taizhen Liang, Haojie Peng, Qiannan Fang, Shiqi Xiao, Sen Liu, Meilin Hu, Fei Yu, Lixue Cao, Yiwen Zhang, Ting Pan, Zhihui Xi, Yao Ding, Linyuan Feng, Tao Zeng, Wenjing Huang, Hui Zhang, Xiancai Ma, . NSP6 inhibits the production of ACE2-containing exosomes to promote SARS-CoV-2 infectivity. mBio 2024, 15 (3) https://doi.org/10.1128/mbio.03358-23
    9. Rui Zhang, Chenfang Miao, Xingyu Lin, Rongjie Lin, Xiaoqin Deng, Jiyue Huang, Yao Wang, Yan Xu, Shaohuang Weng, Min Chen. Carbon dots efficiently promote vascularization for enhanced repairing of orthopedic diseases with diabetic mellitus based on nanocatalytic medicine. Carbon 2024, 217 , 118617. https://doi.org/10.1016/j.carbon.2023.118617
    10. Manxiang Wu, Chengyuan Hong, Chunjuan Shen, Dong Xie, Tianxiang Chen, Aiguo Wu, Qiang Li. Polydopamine nanomaterials and their potential applications in the treatment of autoimmune diseases. Drug Delivery 2023, 30 (1) https://doi.org/10.1080/10717544.2023.2289846
    11. Soumyalekshmi Nair, Estefania Nova-Lamperti, Gonzalo Labarca, Arutha Kulasinghe, Kirsty R. Short, Flavio Carrión, Carlos Salomon. Genomic communication via circulating extracellular vesicles and long-term health consequences of COVID-19. Journal of Translational Medicine 2023, 21 (1) https://doi.org/10.1186/s12967-023-04552-2
    12. Zhicheng Liu, Zhuolei Han, Xin Jin, Jusung An, Jaewon Kim, Wenting Chen, Jong Seung Kim, Ji Zheng, Jun Deng. Regulating the microenvironment with nanomaterials: Potential strategies to ameliorate COVID-19. Acta Pharmaceutica Sinica B 2023, 13 (9) , 3638-3658. https://doi.org/10.1016/j.apsb.2023.02.010
    13. Xiaoyi Ma, Bingbing Liu, Limin Fan, Yiqiong Liu, Yuge Zhao, Tianbin Ren, Yan Li, Yongyong Li. Native and engineered exosomes for inflammatory disease. Nano Research 2023, 16 (5) , 6991-7006. https://doi.org/10.1007/s12274-022-5275-5
    14. Alexandra Mavridi-Printezi, Arianna Menichetti, Dario Mordini, Riccardo Amorati, Marco Montalti. Recent Applications of Melanin-like Nanoparticles as Antioxidant Agents. Antioxidants 2023, 12 (4) , 863. https://doi.org/10.3390/antiox12040863
    15. Chunjiao Zheng, Yuling Shi, Ying Zou. T cell co-stimulatory and co-inhibitory pathways in atopic dermatitis. Frontiers in Immunology 2023, 14 https://doi.org/10.3389/fimmu.2023.1081999
    16. Zhuoqun Fang, Yicheng Lv, Haoruo Zhang, Yuxiang He, Hangqi Gao, Caixiang Chen, Dezhi Wang, Penghong Chen, Shijie Tang, Junjing Li, Zhihuang Qiu, Xian'ai Shi, Liangwan Chen, Jianmin Yang, Xiaosong Chen. A multifunctional hydrogel loaded with two nanoagents improves the pathological microenvironment associated with radiation combined with skin wounds. Acta Biomaterialia 2023, 159 , 111-127. https://doi.org/10.1016/j.actbio.2023.01.052
    17. Takwa Bedhiafi, Sourour Idoudi, Areej Ali Alhams, Queenie Fernandes, Heba Iqbal, Renuka Basineni, Shahab Uddin, Said Dermime, Maysaloun Merhi, Nashiru Billa. Applications of polydopaminic nanomaterials in mucosal drug delivery. Journal of Controlled Release 2023, 353 , 842-849. https://doi.org/10.1016/j.jconrel.2022.12.037
    18. Peije Russell, Lars Esser, Christoph E. Hagemeyer, Nicolas H. Voelcker. The potential impact of nanomedicine on COVID-19-induced thrombosis. Nature Nanotechnology 2023, 18 (1) , 11-22. https://doi.org/10.1038/s41565-022-01270-6
    19. Xiaohang Chen, Huifei Li, Haoyue Song, Jie Wang, Xiaoxuan Zhang, Pengcheng Han, Xing Wang. Meet changes with constancy: Defence, antagonism, recovery, and immunity roles of extracellular vesicles in confronting SARS‐CoV‐2. Journal of Extracellular Vesicles 2022, 11 (12) https://doi.org/10.1002/jev2.12288
    20. Eugene M. Obeng, Isaac Fianu, Michael K. Danquah. Multivalent ACE2 engineering—A promising pathway for advanced coronavirus nanomedicine development. Nano Today 2022, 46 , 101580. https://doi.org/10.1016/j.nantod.2022.101580

    ACS Applied Materials & Interfaces

    Cite this: ACS Appl. Mater. Interfaces 2022, 14, 4, 4882–4891
    Click to copy citationCitation copied!
    https://doi.org/10.1021/acsami.1c19541
    Published January 22, 2022
    Copyright © 2022 American Chemical Society

    Article Views

    2707

    Altmetric

    -

    Citations

    Learn about these metrics

    Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.

    Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.

    The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated.